SMS Pharmaceuticals Limited

NSE SMSPHARMA.NS

SMS Pharmaceuticals Limited Price to Book Ratio (P/B) on February 06, 2025: 3.24

SMS Pharmaceuticals Limited Price to Book Ratio (P/B) is 3.24 on February 06, 2025, a 35.63% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

SMS Pharmaceuticals Limited 52-week high Price to Book Ratio (P/B) is 5.95 on September 23, 2024, which is 83.93% above the current Price to Book Ratio (P/B).
SMS Pharmaceuticals Limited 52-week low Price to Book Ratio (P/B) is 2.38 on February 07, 2024, which is -26.31% below the current Price to Book Ratio (P/B).
SMS Pharmaceuticals Limited average Price to Book Ratio (P/B) for the last 52 weeks is 3.92.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

NSE: SMSPHARMA.NS

SMS Pharmaceuticals Limited

CEO	Mr. Ramesh Babu Potluri
IPO Date	Feb. 28, 2007
Location	India
Headquarters	Plot No. 72
Employees	1,197
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Key trends

Past 5 years